Ambien IR/Stilnox/Myslee  

EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.

Pharma Class with Mechanism of Action (New)

Mechanism of Action Level 1 Anxiolytic
Mechanism of Action Level 2 GABA receptor agonist
Mechanism of Action Level 3 GABA receptor agonist (unspecified)
Mechanism of Action Level 4 GABA receptor agonist (unspecified)
Mechanism of Action Level 5 GABA receptor agonist (unspecified)

Product Name Information

Product: Ambien IR/Stilnox/Myslee
Generic Name:    zolpidem tartrate
Therapeutic Subcategory:      Sedatives & hypnotics

Clinical Trial Coverage: No. of Trials involving Product

Trial Count
Ambien IR/Stilnox/Myslee1 126


Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.

Explore Evaluate


EvaluatePharma® now includes Partnering Opportunities - products available for licensing.

Partnering Opportunities in EvaluatePharma® are sourced from the rights holders - all entries are verified by the team of Analysts at EvaluatePharma - and presented in their commercial context.

Register to submit your Partnering Opportunities or to see your own and other Partnering Opportunities in their commercial context with the unique industry-wide analysis in EvaluatePharma®.

Take a full subscription to see all products available for license, including updated contact details for the out-licensing entity.

Register to access more FREE content:

  • 2011 Product Sales analysis
  • Download analysis into Excel
  • Search 2 yrs of company press releases

Research Codes Synonyms

Product: Ambien IR/Stilnox/Myslee

Register for Free Analysis

Register to access more free insights and analysis from Evaluate.

Register Now